Utah Medical Products Stock Z Score

UTMD Stock  USD 57.93  0.63  1.10%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Utah Medical Piotroski F Score and Utah Medical Valuation analysis.
  
The current year's Capital Lease Obligations is expected to grow to about 268.5 K, whereas Capital Surpluse is forecasted to decline to about 214.6 K. At present, Utah Medical's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Selling And Marketing Expenses is expected to grow to about 1.5 M, whereas Total Revenue is forecasted to decline to about 36.6 M.

Utah Medical Products Company Z Score Analysis

Utah Medical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Utah Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Utah Medical is extremely important. It helps to project a fair market value of Utah Stock properly, considering its historical fundamentals such as Z Score. Since Utah Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Utah Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Utah Medical's interrelated accounts and indicators.
0.98-0.850.970.49-0.180.93-0.36-0.22-0.38-0.780.480.80.47-0.280.68-0.56-0.41-0.05-0.610.810.76-0.69
0.98-0.921.00.38-0.380.97-0.5-0.23-0.54-0.680.550.850.33-0.40.75-0.6-0.47-0.1-0.610.850.79-0.7
-0.85-0.92-0.93-0.150.61-0.950.730.340.740.42-0.65-0.83-0.050.48-0.770.570.590.130.45-0.87-0.840.57
0.971.0-0.930.37-0.390.96-0.51-0.27-0.57-0.680.570.840.32-0.40.75-0.61-0.52-0.13-0.590.840.78-0.68
0.490.38-0.150.370.370.230.390.260.2-0.72-0.150.290.69-0.10.29-0.380.180.02-0.040.130.08-0.06
-0.18-0.380.61-0.390.37-0.430.750.150.89-0.28-0.47-0.440.520.64-0.510.390.410.290.16-0.42-0.380.21
0.930.97-0.950.960.23-0.43-0.66-0.32-0.57-0.520.580.850.15-0.320.68-0.45-0.55-0.06-0.670.910.88-0.76
-0.36-0.50.73-0.510.390.75-0.660.490.75-0.25-0.68-0.620.580.27-0.360.040.650.060.42-0.67-0.660.5
-0.22-0.230.34-0.270.260.15-0.320.490.34-0.06-0.72-0.390.29-0.390.13-0.220.83-0.340.11-0.38-0.340.16
-0.38-0.540.74-0.570.20.89-0.570.750.34-0.02-0.64-0.520.360.59-0.610.450.620.380.21-0.49-0.430.27
-0.78-0.680.42-0.68-0.72-0.28-0.52-0.25-0.06-0.02-0.12-0.36-0.870.17-0.550.610.040.160.3-0.37-0.330.33
0.480.55-0.650.57-0.15-0.470.58-0.68-0.72-0.64-0.120.61-0.15-0.240.41-0.25-0.810.0-0.220.60.52-0.3
0.80.85-0.830.840.29-0.440.85-0.62-0.39-0.52-0.360.610.04-0.240.5-0.32-0.580.17-0.490.890.78-0.6
0.470.33-0.050.320.690.520.150.580.290.36-0.87-0.150.04-0.030.36-0.510.34-0.050.00.120.11-0.02
-0.28-0.40.48-0.4-0.10.64-0.320.27-0.390.590.17-0.24-0.24-0.03-0.80.75-0.030.470.04-0.2-0.160.07
0.680.75-0.770.750.29-0.510.68-0.360.13-0.61-0.550.410.50.36-0.8-0.88-0.15-0.39-0.190.580.58-0.27
-0.56-0.60.57-0.61-0.380.39-0.450.04-0.220.450.61-0.25-0.32-0.510.75-0.88-0.040.350.0-0.34-0.310.05
-0.41-0.470.59-0.520.180.41-0.550.650.830.620.04-0.81-0.580.34-0.03-0.15-0.04-0.030.25-0.55-0.480.33
-0.05-0.10.13-0.130.020.29-0.060.06-0.340.380.160.00.17-0.050.47-0.390.35-0.030.070.150.130.04
-0.61-0.610.45-0.59-0.040.16-0.670.420.110.210.3-0.22-0.490.00.04-0.190.00.250.07-0.49-0.440.98
0.810.85-0.870.840.13-0.420.91-0.67-0.38-0.49-0.370.60.890.12-0.20.58-0.34-0.550.15-0.490.97-0.62
0.760.79-0.840.780.08-0.380.88-0.66-0.34-0.43-0.330.520.780.11-0.160.58-0.31-0.480.13-0.440.97-0.57
-0.69-0.70.57-0.68-0.060.21-0.760.50.160.270.33-0.3-0.6-0.020.07-0.270.050.330.040.98-0.62-0.57
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

As per the company's disclosures, Utah Medical Products has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Utah Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Utah Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Utah Medical's managers, analysts, and investors.
Environmental
Governance
Social

Utah Medical Institutional Holders

Institutional Holdings refers to the ownership stake in Utah Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Utah Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Utah Medical's value.
Shares
Minerva Advisors Llc2024-12-31
78.4 K
Hotchkis & Wiley Capital Management Llc2024-12-31
75.2 K
Bank Of New York Mellon Corp2024-12-31
47.3 K
Acadian Asset Management Llc2024-12-31
43.2 K
Royce & Associates, Lp2024-12-31
42 K
Northern Trust Corp2024-12-31
36.8 K
Morgan Stanley - Brokerage Accounts2024-12-31
36.4 K
Millennium Management Llc2024-12-31
32.1 K
Isthmus Partners Llc2024-12-31
31.5 K
Renaissance Technologies Corp2024-12-31
221.5 K
Dimensional Fund Advisors, Inc.2024-12-31
186.7 K

Utah Fundamentals

About Utah Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Utah Medical Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Utah Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Utah Medical Products based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.27)
Dividend Share
1.205
Earnings Share
3.96
Revenue Per Share
11.677
Quarterly Revenue Growth
(0.26)
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.